Abiomed Inc (ABMD)

265.07 -11.07  -4.01% NASDAQ Sep 18, 20:00 USD

Abiomed Cash from Investing (Quarterly):

13.76M for June 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (Quarterly) Data

View and export this data going back to 1991. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2020 13.76M
March 31, 2020 9.961M
Dec. 31, 2019 -97.40M
Sept. 30, 2019 7.926M
June 30, 2019 -45.94M
March 31, 2019 -35.75M
Dec. 31, 2018 -65.82M
Sept. 30, 2018 -49.65M
June 30, 2018 34.77M
March 31, 2018 -68.46M
Dec. 31, 2017 -51.71M
Sept. 30, 2017 -43.38M
June 30, 2017 -17.21M
March 31, 2017 -69.22M
Dec. 31, 2016 -29.11M
Sept. 30, 2016 -2.676M
June 30, 2016 -25.33M
March 31, 2016 -29.63M
Dec. 31, 2015 -26.36M
Sept. 30, 2015 -7.457M
June 30, 2015 5.739M
March 31, 2015 -16.16M
Dec. 31, 2014 -18.73M
Sept. 30, 2014 -25.80M
June 30, 2014 10.83M
   
March 31, 2014 -13.16M
Dec. 31, 2013 0.968M
Sept. 30, 2013 -10.97M
June 30, 2013 0.888M
March 31, 2013 -4.441M
Dec. 31, 2012 9.049M
Sept. 30, 2012 -8.403M
June 30, 2012 -6.47M
March 31, 2012 -6.558M
Dec. 31, 2011 -8.784M
Sept. 30, 2011 -1.165M
June 30, 2011 -0.973M
March 31, 2011 -0.251M
Dec. 31, 2010 -5.464M
Sept. 30, 2010 0.914M
June 30, 2010 2.449M
March 31, 2010 0.999M
Dec. 31, 2009 1.041M
Sept. 30, 2009 2.138M
June 30, 2009 4.64M
March 31, 2009 1.427M
Dec. 31, 2008 0.134M
Sept. 30, 2008 -37.38M
June 30, 2008 9.009M
March 31, 2008 2.821M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Benchmarks

Regeneron Pharmaceuticals Inc 1.453B
IDEXX Laboratories Inc -24.56M
West Pharmaceutical Services Inc -40.90M

Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -97.40M Dec 2019
Maximum 34.77M Jun 2018
Average -29.93M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.